197
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Experience with revision craniovertebral decompression in adult patients with Chiari malformation type 1, with or without syringomyelia

, , , &
Pages 750-755 | Received 04 Feb 2020, Accepted 11 Sep 2020, Published online: 23 Sep 2020
 

Abstract

Background

Craniovertebral decompression is performed for symptomatic Chiari malformation type 1, with or without syringomyelia. In a few patients the symptoms and/or syrinx persist or recur, in which case revision surgery may be offered. The aim of this study was to examine the cause of failure of primary surgery and to assess the outcomes for revision cranio-vertebral decompression.

Methods

We retrospectively reviewed all revision cranio-vertebral decompressions performed in our centre over an eighteen-year period. A total of 35 patients were identified (23 females; 12 males). Twenty patients had isolated Chiari malformation type 1 and a further fifteen had associated syringomyelia. The mean follow up period was 4-years (range:1–12 years).

Results

The mean time to revision was 7 years after the primary surgery. The commonest operative finding was that of dense arachnoid scar tissue, obstructing movement of CSF across the craniovertebral junction. Overall, 32 of the 35 patients reported improvement after surgery, including all 15 patients with syringomyelia. Improvement was maintained in the longer term in more than two thirds of those patients who underwent revision craniovertebral decompression.

Conclusions

Failure of primary craniovertebral decompression for Chiari malformation most often results from the formation dense scar tissue at the operation site, obstructing CSF movement. Revision cranio-vertebral decompression can provide early symptomatic relief in most patients and this benefit is sustained in at least two thirds of cases, in the medium term at least. Patients with concomitant syringomyelia appear to derive most benefit from revision surgery.

Ethical approval

This is a retrospective review of clinical cases operated on for the purposes of treatment of recurrent symptoms in the context of Chiari 1 type malformation with or without syringomyelia. All procedures performed in studies involving human participants were in accordance with the ethical standards or the institutional research committee (Queen Elizabeth University Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This is a retrospective study and therefore for this type of study formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study for the operative procedures they underwent.

Disclosure statement

All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.